Reason for request
Renouvellement d'inscription
Clinical Benefit
| Substantial |
La Commission considère que le service médical rendu par CHIBROXINE, 0,3 % reste important dans les indications de l'AMM.
|
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
gK4UqMmKjUz0zZyL
Listen
